Pandemic linked to 16% rise in babies born with heart defects

The proportion of babies born with a congenital heart abnormality increased by 16 per cent after the first year of the pandemic, according to research at City St George’s, University of London and published today in Ultrasound in Obstetrics and Gynecology.

NICE expands access of Paxlovid to further 1.4 million Covid-19 patients – Pharmaceutical Technology

Share this article Paxlovid saw peak global sales of $18.9bn in 2022. Image credit: Shutterstock/MargJohnsonVA. An additional 1.4 million people in England and Wales who

January 11, 2024

House committee probes FTC disclosure of confidential info in reviewing Amgen-Horizon deal

House Oversight Committee Chair James Comer (R-KY) sent a stern letter to FTC chair Lina Khan last week, claiming the commission improperly disclosed confidential information

November 28, 2023

FDA grants RMAT designation to Poseida’s P-BCMA-ALLO1

P-BCMA-ALLO1 is licensed to Roche for the treatment of relapsed/refractory multiple myeloma. Credit: SkazovD/Shutterstock. Poseida Therapeutics has received the Regenerative Medicine Advanced Therapy (RMAT) designation

September 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.